Cell Lysis & Disruption Market Analysis by Product (Reagents, Instruments, Enzymes), by Technique (Physical Disruption, Reagent-Based), by Cell Type, by Application (Cell Organelle, Protein, Nucleic Acid), by End Use, and by Region - Forecast to 2029

The global cell lysis & disruption market size is estimated to be USD 3,997.0 million in 2021 and is expected to witness a CAGR of 9.76% during the forecast period. Increasing acceptance of advanced lysis & disruption techniques throughout downstream processing for the production of biologics is a key driver for the growth of the global cell lysis & disruption market. Additionally, increase in prevalence of chronic diseases, outbreak of the COVID-19 pandemic, government and private funding for research activities, and market expansion by biotechnology companies are some of the other drivers propelling the market growth. However, high cost of process implementation and lack of skilled professionals are expected to restrain the global market growth.

Global Cell Lysis & Disruption Market Size (USD Million), 2021-2029

Source: Erevna Healthcare

By Product

Based on product, the market is segmented into kits & reagents, consumables, instruments, and enzymes. In 2021, the consumables segment accounted for the largest revenue share. This is attributed to the selective product release application coupled with controlled lysis, thereby providing biological uniqueness to the process. The enzymes segment is expected to grow at the fastest CAGR during the forecast period. This is attributed to the rising availability of varied enzymes for mammalian, bacterial, yeast, and plant samples.

By Technique

Based on technique, the market is segmented into physical disruption and reagent-based. In 2021, the physical disruption segment accounted for a significant revenue share, however is expected to grow with a decreasing CAGR during the forecast period. This is attributed to the bulky built and high cost of equipment. Reagent-based segment is anticipated to grow at the fastest CAGR during the forecast period. This is attributed to the fact that they safeguard the native activity of the final biological products that are less harmful and preferably suited for samples in the laboratory.

By Cell Type

Based on cell type, the market is categorized into bacterial cells, mammalian cells, plant cells, and yeast/algae/fungi. In 2021, the mammalian cells method accounted for the largest revenue share and is expected to dominate during the forecast period. This is owing to its extensive usage in biologics manufacturing including vaccines and therapeutic proteins. This segment is anticipated to grow at a lucrative CAGR during the forecast period, owing to the acceptance of 3D mammalian culture systems in cancer research and stem cell application.

By Application

Based on application, the market is categorized into cell organelle isolation, downstream processing, protein isolation, and nucleic acid isolation. The downstream processing and protein isolation segment accounted for the maximum revenue in 2021. The protein isolation segment is expected to grow at a profitable CAGR during the forecast period due to rise in the need for quick and efficient techniques for cell lysis that enable extraction of proteins with minimal oxidation or breakdown.

By End Use

Based on end use, the market is categorized into pharmaceutical & biotechnology companies, academic & research institutes, cell banks, and hospitals & diagnostic labs. The academic & research institutes segment accounted for the highest revenue in 2021. Rising biotechnology research institutes, especially including molecular and cellular biology courses is a key factor that drives the segment growth. The hospitals and diagnostic labs segment is anticipated to grow at a lucrative CAGR during the forecast period owing to rising drug development projects worldwide.

Regional Insights

In 2021, North America accounted for the highest revenue share in the global market and is expected to maintain its dominance during the forecast period. This is attributed to the heavy government funding and favorable support coupled with the presence of leading biotechnology & biopharmaceutical companies and institutes in this region. Asia Pacific market is expected to exhibit the fastest CAGR over the forecast period owing to the growing focus of CROs & biopharmaceutical companies in this region to gain higher profitability.

Competitor Insights

Some of the key players in the cell lysis & disruption market are Merck KGaA (Germany); Becton, Dickinson and Company (U.S.); Miltenyi Biotec B.V. & CO. KG (Germany), Danaher Corporation (U.S.); Cell Signaling Technology, Inc. (U.S.); Promega Corporation (U.S.); IDEX Corporation (U.S.); Bio-Rad Laboratories, Inc. (U.S.); QIAGEN N.V. (Germany); Thermo Fisher Scientific (U.S.) and F. Hoffmann-La Roche AG (Switzerland). The leading players operating in the cell lysis & disruption industry are adopting various strategies including R&D investments, adaption of advanced techniques, mergers & acquisitions, and regional expansions to capture a maximum revenue share.

This exhaustive research report focuses on market size and forecast at global, segmental, regional and country level along with key market trends and dynamics from 2021 to 2029. The cell lysis & disruption market report is categorized into the following segments and subsegments:

Cell Lysis & Disruption Market, By Product (Revenue, USD Million, 2021-2029)

  • Kits & Reagents
  • Consumables
  • Instruments
    • High-Pressure Homogenizers
    • Bead Mill
    • Sonicator
    • Microfluidizer
    • French Press
    • Other Instruments
  • Enzymes
    • Zwitterionic detergent
    • Detergent Solutions
    • Non-ionic detergent
    • Ionic detergent

Cell Lysis & Disruption Market, By Technique (Revenue, USD Million, 2021-2029)

  • Physical Disruption
    • Temperature Treatments
    • Mechanical Homogenization
    • Pressure Homogenization
    • Ultrasonic Homogenization
  • Reagent-Based
    • Enzymatic
    • Detergent

Cell Lysis & Disruption Market, By Cell Type (Revenue, USD Million, 2021-2029)

  • Bacterial cells
  • Mammalian cells
  • Plant cells
  • Yeast/Algae/Fungi

Cell Lysis & Disruption Market, By Application (Revenue, USD Million, 2021-2029)

  • Cell organelle isolation
  • Downstream Processing
  • Protein Isolation
  • Nucleic acid isolation

Cell Lysis & Disruption Market, By End-Use (Revenue, USD Million, 2021-2029)

  • Pharmaceutical & Biotechnology Companies
  • Academic & Research Institutes
  • Cell Banks
  • Hospitals & Diagnostic Labs

Cell Lysis & Disruption Market, By Region (Revenue, USD Million, 2021-2029)

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Spain
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of APAC
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Rest of LATAM
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • Rest of MEA

Scope of Cell Culture Market Report:

Key Parameters Details
Base Year
  • 2021
Forecast Period
  • 2022-2029
Study Coverage
  • Global and regional market size and revenue forecast
  • Segment market size and revenue forecast at global, regional, and country level
  • Competitive landscape (company share analysis, company profiles, recent development, competitive map analysis)
  • Conclusion and recommendations
Qualitative Analysis
  • Market drivers
  • Market restraints
  • Market opportunities
  • Recent market trends
  • Market challenges
  • Porter’s Five Forces analysis
  • PEST analysis
  • Value-chain analysis
  • COVID-19 impact analysis
Regional Market Scope
  • North America (U.S. and Canada)
  • Europe (Germany, France, UK, Spain, Italy, Russia, Rest of Europe)
  • Asia Pacific (China, Japan, India, Australia, South Korea, Rest of APAC)
  • Latin America (Brazil, Mexico, Argentina, Rest of LATAM)
  • MEA (South Africa, GCC, Rest of MEA)
Company Profiles
  • Exhaustive profiles of top 15 players
  • 50+ other major players listing
15% Free Customization Available
  • You can customize the study scope to meet your exact requirement. Click here for more details

Table of Contents: Cell Lysis & Disruption Market 2020-2031

  1. Research Methodology
    1. Study Objectives
    2. Study Scope
    3. Research Assumptions
    4. Research Framework
      1. Research Models
        1. Bottom-up Approach
        2. Top-down Approach
        3. Data Triangulation
      2. Data Procurement
        1. Internal Database
        2. Secondary Research
        3. Purchased Database
        4. Primary Research
      3. Data Analysis
        1. Data Validation
        2. Market Size Estimation
        3. Market Forecast Model
      4. Quality Assessment
  1. Introduction: Cell Lysis & Disruption
  2. Executive Summary
    1. Global Market Scenario
    2. Segment Market Scenario
    3. Geographic Market Scenario
    4. COVID-19 Impact
    5. Competitive Landscape
  3. Market Dynamics
    1. Market Drivers
      1. Driver 1
      2. Driver 2
      3. Driver 3
      4. Driver 4
      5. Driver 5
    2. Market Restraint
      1. Restraint 1
      2. Restraint 2
      3. Restraint 3
      4. Restraint 4
    3. Market Opportunities
      1. Opportunity 1
      2. Opportunity 2
      3. Opportunity 3
      4. Opportunity 4
    4. Market Trends
      1. Trend 1
      2. Trend 2
      3. Trend 3
      4. Trend 4
    5. Market Challenges
      1. Challenge 1
      2. Challenge 2
      3. Challenge 3
      4. Challenge 4
  1. Market Environment Analysis
    1. Porter’s 5 Forces Analysis
    2. PESTEL Analysis
    3. Value Chain Analysis
    4. SWOT Analysis
    5. Benchmark
  2. COVID-19 Impact Analysis: Cell Lysis & Disruption Market
    1. COVID-19: Overview
    2. COVID-19 Impact on the Global Market
    3. COVID-19 Impact on the Regional Markets
  3. Market Analysis by Product
    1. Clinical
      1. Clinical Market Forecast, 2020-2031 (USD Million)
    2. Pre-clinical
      1. Pre-clinical Market Forecast, 2020-2031 (USD Million)
  1. Market Analysis by Technique
    1. ADA
      1. ADA Market Forecast, 2020-2031 (USD Million)
    2. Pharmacokinetics
      1. Pharmacokinetics Market Forecast, 2020-2031 (USD Million)
    3. Others
      1. Others Market Forecast, 2020-2031 (USD Million)
  1. Market Analysis by Cell Type
    1. Bioequivalence
      1. Bioequivalence Market Forecast, 2020-2031 (USD Million)
    2. Bio availability
      1. Bio availability Market Forecast, 2020-2031 (USD Million)
    3. ADME
      1. ADME Market Forecast, 2020-2031 (USD Million)
    4. PD
      1. PD Market Forecast, 2020-2031 (USD Million)
    5. PK
      1. PK Market Forecast, 2020-2031 (USD Million)
    6. Others
      1. Others Market Forecast, 2020-2031 (USD Million)
  1. Market Analysis by Application
    1. Infectious Disease
      1. Infectious Disease Market Forecast, 2020-2031 (USD Million)
    2. Oncology
      1. Oncology Market Forecast, 2020-2031 (USD Million)
    3. Neurology
      1. Neurology Market Forecast, 2020-2031 (USD Million)
    4. Cardiology
      1. Cardiology Market Forecast, 2020-2031 (USD Million)
    5. Others
      1. Others Market Forecast, 2020-2031 (USD Million)
  1. Market Analysis by End use
    1. Large Firms
      1. Large Firms Market Forecast, 2020-2031 (USD Million)
    2. SMEs
      1. SMEs Market Forecast, 2020-2031 (USD Million)
  1. Regional Market Analysis
    1. Regional Market Trends
    2. Regional Market: Comparative Analysis
  2. North America Cell Lysis & Disruption Market
    1. North America Cell Lysis & Disruption Market
      1. North America Market Size and Forecast, 2020-2031 (USD Million)
        1. Market Size and Forecast by Product, 2020-2031 (USD Million)
        2. Market Size and Forecast by Technique, 2020-2031 (USD Million)
        3. Market Size and Forecast by Cell Type, 2020-2031 (USD Million)
        4. Market Size and Forecast by Application, 2020-2031 (USD Million)
        5. Market Size and Forecast by End use, 2020-2031 (USD Million)
      2. S. Cell Lysis & Disruption Market
        1. S. Market Size and Forecast, 2020-2031 (USD Million)
          1. Market Size and Forecast by Product, 2020-2031 (USD Million)
          2. Market Size and Forecast by Technique, 2020-2031 (USD Million)
          3. Market Size and Forecast by Cell Type, 2020-2031 (USD Million)
          4. Market Size and Forecast by Application, 2020-2031 (USD Million)
          5. Market Size and Forecast by End use, 2020-2031 (USD Million)
        2. Canada Cell Lysis & Disruption Market
          1. Canada Market Size and Forecast, 2020-2031 (USD Million)
            1. Market Size and Forecast by Product, 2020-2031 (USD Million)
            2. Market Size and Forecast by Technique, 2020-2031 (USD Million)
            3. Market Size and Forecast by Cell Type, 2020-2031 (USD Million)
            4. Market Size and Forecast by Application, 2020-2031 (USD Million)
            5. Market Size and Forecast by End use, 2020-2031 (USD Million)
  1. Europe Cell Lysis & Disruption Market
    1. Europe Cell Lysis & Disruption Market
      1. Europe Market Size and Forecast, 2020-2031 (USD Million)
        1. Market Size and Forecast by Product, 2020-2031 (USD Million)
        2. Market Size and Forecast by Technique, 2020-2031 (USD Million)
        3. Market Size and Forecast by Cell Type, 2020-2031 (USD Million)
        4. Market Size and Forecast by Application, 2020-2031 (USD Million)
        5. Market Size and Forecast by End use, 2020-2031 (USD Million)
      2. Germany Cell Lysis & Disruption Market
        1. Germany Market Size and Forecast, 2020-2031 (USD Million)
          1. Market Size and Forecast by Product, 2020-2031 (USD Million)
          2. Market Size and Forecast by Technique, 2020-2031 (USD Million)
          3. Market Size and Forecast by Cell Type, 2020-2031 (USD Million)
          4. Market Size and Forecast by Application, 2020-2031 (USD Million)
          5. Market Size and Forecast by End use, 2020-2031 (USD Million)
        2. UK Cell Lysis & Disruption Market
          1. UK Market Size and Forecast, 2020-2031 (USD Million)
            1. Market Size and Forecast by Product, 2020-2031 (USD Million)
            2. Market Size and Forecast by Technique, 2020-2031 (USD Million)
            3. Market Size and Forecast by Cell Type, 2020-2031 (USD Million)
            4. Market Size and Forecast by Application, 2020-2031 (USD Million)
            5. Market Size and Forecast by End use, 2020-2031 (USD Million)
          2. France Cell Lysis & Disruption Market
            1. France Market Size and Forecast, 2020-2031 (USD Million)
              1. Market Size and Forecast by Product, 2020-2031 (USD Million)
              2. Market Size and Forecast by Technique, 2020-2031 (USD Million)
              3. Market Size and Forecast by Cell Type, 2020-2031 (USD Million)
              4. Market Size and Forecast by Application, 2020-2031 (USD Million)
              5. Market Size and Forecast by End use, 2020-2031 (USD Million)
            2. Spain Cell Lysis & Disruption Market
              1. Spain Market Size and Forecast, 2020-2031 (USD Million)
                1. Market Size and Forecast by Product, 2020-2031 (USD Million)
                2. Market Size and Forecast by Technique, 2020-2031 (USD Million)
                3. Market Size and Forecast by Cell Type, 2020-2031 (USD Million)
                4. Market Size and Forecast by Application, 2020-2031 (USD Million)
                5. Market Size and Forecast by End use, 2020-2031 (USD Million)
              2. Italy Cell Lysis & Disruption Market
                1. Italy Market Size and Forecast, 2020-2031 (USD Million)
                  1. Market Size and Forecast by Product, 2020-2031 (USD Million)
                  2. Market Size and Forecast by Technique, 2020-2031 (USD Million)
                  3. Market Size and Forecast by Cell Type, 2020-2031 (USD Million)
                  4. Market Size and Forecast by Application, 2020-2031 (USD Million)
                  5. Market Size and Forecast by End use, 2020-2031 (USD Million)
                2. Rest of Europe Cell Lysis & Disruption Market
                  1. Rest of Europe Market Size and Forecast, 2020-2031 (USD Million)
                    1. Market Size and Forecast by Product, 2020-2031 (USD Million)
                    2. Market Size and Forecast by Technique, 2020-2031 (USD Million)
                    3. Market Size and Forecast by Cell Type, 2020-2031 (USD Million)
                    4. Market Size and Forecast by Application, 2020-2031 (USD Million)
                    5. Market Size and Forecast by End use, 2020-2031 (USD Million)
  1. Asia Pacific Cell Lysis & Disruption Market
    1. Asia Pacific Cell Lysis & Disruption Market
      1. Asia Pacific Market Size and Forecast, 2020-2031 (USD Million)
        1. Market Size and Forecast by Product, 2020-2031 (USD Million)
        2. Market Size and Forecast by Technique, 2020-2031 (USD Million)
        3. Market Size and Forecast by Cell Type, 2020-2031 (USD Million)
        4. Market Size and Forecast by Application, 2020-2031 (USD Million)
        5. Market Size and Forecast by End use, 2020-2031 (USD Million)
      2. Japan Cell Lysis & Disruption Market
        1. Japan Market Size and Forecast, 2020-2031 (USD Million)
          1. Market Size and Forecast by Product, 2020-2031 (USD Million)
          2. Market Size and Forecast by Technique, 2020-2031 (USD Million)
          3. Market Size and Forecast by Cell Type, 2020-2031 (USD Million)
          4. Market Size and Forecast by Application, 2020-2031 (USD Million)
          5. Market Size and Forecast by End use, 2020-2031 (USD Million)
        2. China Cell Lysis & Disruption Market
          1. China Market Size and Forecast, 2020-2031 (USD Million)
            1. Market Size and Forecast by Product, 2020-2031 (USD Million)
            2. Market Size and Forecast by Technique, 2020-2031 (USD Million)
            3. Market Size and Forecast by Cell Type, 2020-2031 (USD Million)
            4. Market Size and Forecast by Application, 2020-2031 (USD Million)
            5. Market Size and Forecast by End use, 2020-2031 (USD Million)
          2. India Cell Lysis & Disruption Market
            1. India Market Size and Forecast, 2020-2031 (USD Million)
              1. Market Size and Forecast by Product, 2020-2031 (USD Million)
              2. Market Size and Forecast by Technique, 2020-2031 (USD Million)
              3. Market Size and Forecast by Cell Type, 2020-2031 (USD Million)
              4. Market Size and Forecast by Application, 2020-2031 (USD Million)
              5. Market Size and Forecast by End use, 2020-2031 (USD Million)
            2. South Korea Cell Lysis & Disruption Market
              1. South Korea Market Size and Forecast, 2020-2031 (USD Million)
                1. Market Size and Forecast by Product, 2020-2031 (USD Million)
                2. Market Size and Forecast by Technique, 2020-2031 (USD Million)
                3. Market Size and Forecast by Cell Type, 2020-2031 (USD Million)
                4. Market Size and Forecast by Application, 2020-2031 (USD Million)
                5. Market Size and Forecast by End use, 2020-2031 (USD Million)
              2. Australia Cell Lysis & Disruption Market
                1. Australia Market Size and Forecast, 2020-2031 (USD Million)
                  1. Market Size and Forecast by Product, 2020-2031 (USD Million)
                  2. Market Size and Forecast by Technique, 2020-2031 (USD Million)
                  3. Market Size and Forecast by Cell Type, 2020-2031 (USD Million)
                  4. Market Size and Forecast by Application, 2020-2031 (USD Million)
                  5. Market Size and Forecast by End use, 2020-2031 (USD Million)
                2. Rest of Asia Pacific Cell Lysis & Disruption Market
                  1. Rest of Asia Pacific Market Size and Forecast, 2020-2031 (USD Million)
                    1. Market Size and Forecast by Product, 2020-2031 (USD Million)
                    2. Market Size and Forecast by Technique, 2020-2031 (USD Million)
                    3. Market Size and Forecast by Cell Type, 2020-2031 (USD Million)
                    4. Market Size and Forecast by Application, 2020-2031 (USD Million)
                    5. Market Size and Forecast by End use, 2020-2031 (USD Million)
  1. Latin America Cell Lysis & Disruption Market
    1. Latin America Cell Lysis & Disruption Market
      1. Latin America Market Size and Forecast, 2020-2031 (USD Million)
        1. Market Size and Forecast by Product, 2020-2031 (USD Million)
        2. Market Size and Forecast by Technique, 2020-2031 (USD Million)
        3. Market Size and Forecast by Cell Type, 2020-2031 (USD Million)
        4. Market Size and Forecast by Application, 2020-2031 (USD Million)
        5. Market Size and Forecast by End use, 2020-2031 (USD Million)
      2. Brazil Cell Lysis & Disruption Market
        1. Brazil Market Size and Forecast, 2020-2031 (USD Million)
          1. Market Size and Forecast by Product, 2020-2031 (USD Million)
          2. Market Size and Forecast by Technique, 2020-2031 (USD Million)
          3. Market Size and Forecast by Cell Type, 2020-2031 (USD Million)
          4. Market Size and Forecast by Application, 2020-2031 (USD Million)
          5. Market Size and Forecast by End use, 2020-2031 (USD Million)
        2. Mexico Cell Lysis & Disruption Market
          1. Mexico Market Size and Forecast, 2020-2031 (USD Million)
            1. Market Size and Forecast by Product, 2020-2031 (USD Million)
            2. Market Size and Forecast by Technique, 2020-2031 (USD Million)
            3. Market Size and Forecast by Cell Type, 2020-2031 (USD Million)
            4. Market Size and Forecast by Application, 2020-2031 (USD Million)
            5. Market Size and Forecast by End use, 2020-2031 (USD Million)
          2. Argentina Cell Lysis & Disruption Market
            1. Argentina Market Size and Forecast, 2020-2031 (USD Million)
              1. Market Size and Forecast by Product, 2020-2031 (USD Million)
              2. Market Size and Forecast by Technique, 2020-2031 (USD Million)
              3. Market Size and Forecast by Cell Type, 2020-2031 (USD Million)
              4. Market Size and Forecast by Application, 2020-2031 (USD Million)
              5. Market Size and Forecast by End use, 2020-2031 (USD Million)
            2. Rest of Latin America Cell Lysis & Disruption Market
              1. Rest of Latin America Market Size and Forecast, 2020-2031 (USD Million)
                1. Market Size and Forecast by Product, 2020-2031 (USD Million)
                2. Market Size and Forecast by Technique, 2020-2031 (USD Million)
                3. Market Size and Forecast by Cell Type, 2020-2031 (USD Million)
                4. Market Size and Forecast by Application, 2020-2031 (USD Million)
                5. Market Size and Forecast by End use, 2020-2031 (USD Million)

 

  1. MEA Cell Lysis & Disruption Market
    1. MEA Cell Lysis & Disruption Market
      1. MEA Market Size and Forecast, 2020-2031 (USD Million)
        1. Market Size and Forecast by Product, 2020-2031 (USD Million)
        2. Market Size and Forecast by Technique, 2020-2031 (USD Million)
        3. Market Size and Forecast by Cell Type, 2020-2031 (USD Million)
        4. Market Size and Forecast by Application, 2020-2031 (USD Million)
        5. Market Size and Forecast by End use, 2020-2031 (USD Million)
      2. GCC Cell Lysis & Disruption Market
        1. GCC Market Size and Forecast, 2020-2031 (USD Million)
          1. Market Size and Forecast by Product, 2020-2031 (USD Million)
          2. Market Size and Forecast by Technique, 2020-2031 (USD Million)
          3. Market Size and Forecast by Cell Type, 2020-2031 (USD Million)
          4. Market Size and Forecast by Application, 2020-2031 (USD Million)
          5. Market Size and Forecast by End use, 2020-2031 (USD Million)
        2. South Africa Cell Lysis & Disruption Market
          1. South Africa Market Size and Forecast, 2020-2031 (USD Million)
            1. Market Size and Forecast by Product, 2020-2031 (USD Million)
            2. Market Size and Forecast by Technique, 2020-2031 (USD Million)
            3. Market Size and Forecast by Cell Type, 2020-2031 (USD Million)
            4. Market Size and Forecast by Application, 2020-2031 (USD Million)
            5. Market Size and Forecast by End use, 2020-2031 (USD Million)
          2. Rest of MEA Cell Lysis & Disruption Market
            1. Rest of MEA Market Size and Forecast, 2020-2031 (USD Million)
              1. Market Size and Forecast by Product, 2020-2031 (USD Million)
              2. Market Size and Forecast by Technique, 2020-2031 (USD Million)
              3. Market Size and Forecast by Cell Type, 2020-2031 (USD Million)
              4. Market Size and Forecast by Application, 2020-2031 (USD Million)
              5. Market Size and Forecast by End use, 2020-2031 (USD Million)
  1. Competitor Analysis
    1. Market Share Analysis, 2021 & 2029
    2. Competitive Mapping
    3. Key Players Market Place Analysis
    4. Major Recent Developments
  2. Company Profiles
    1. Merck KGaA (Germany)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    2. Becton, Dickinson and Company (U.S.)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    3. Miltenyi Biotec B.V. & CO. KG (Germany)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    4. Danaher Corporation (U.S.)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    5. Cell Signaling Technology, Inc. (U.S.)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    6. Promega Corporation (U.S.)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    7. IDEX Corporation (U.S.)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    8. Bio-Rad Laboratories, Inc. (U.S.)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    9. QIAGEN N.V. (Germany)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    10. Thermo Fisher Scientific (U.S.)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    11. Hoffmann-La Roche AG (Switzerland)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    12. Company 12
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    13. Company 13
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    14. Company 14
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    15.                 Company 15
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    16. Others Prominent Players

Conclusion & Recommendations

Select License Type

7 Reasons to Choose EHMR Reports

  • Customer’s Satisfaction

    First and foremost client’s satisfaction, which is very important for Erevna Healthcare and we are committed towards it

  • Client Report

    Customised reports

    Expert in healthcare domain and in depth insights on the report. Erevna Healthcare also customise reports as per the client’s requirement

  • Analyst Support

    Experienced team of analysts with strong background in Pharma, Life Sciences and Biotechnology

  • Assured Quality

    Each report passes through three tiers of quality check

  • Stick to the timeline

    Stick to the timeline

    Erevna Healthcare analysts stick to the timeline

  • Quick delivery

    Quick delivery of reports as per client’s request in three different forms i.e. pdf, ppt and word

  • 24x7 Supprt

    24*7 Support

    24*7 Support post delivery/dispatch of all the reports